Investigate the Feasibility of Chitinase-3-Like-1 (Chi3l1) Specific Antibody and Its Antigen Recognition Sites as a Novel Diagnostic Medication for Epithelial Ovarian Cancer = 探討以卵巢癌特異性抗體CHI3L1及其抗原辨識區作為卵巢癌診斷藥物之可行性
 

Investigate the Feasibility of Chitinase-3-Like-1 (Chi3l1) Specific Antibody and Its Antigen Recognition Sites as a Novel Diagnostic Medication for Epithelial Ovarian Cancer = 探討以卵巢癌特異性抗體CHI3L1及其抗原辨識區作為卵巢癌診斷藥物之可行性

Project title
探討以卵巢癌特異性抗體CHI3L1及其抗原辨識區作為卵巢癌診斷藥物之可行性
Internal ID
MOST109-2623-E002-004-NU
Principal Investigator
Start Date
January 1, 2020
End Date
December 31, 2020
Organizations
Partner Organizations

臺大位居世界頂尖大學之列，為永久珍藏及向國際展現本校豐碩的研究成果及學術能量，圖書館整合機構典藏（NTUR）與學術庫（AH）不同功能平台，成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動，應用在學術研究上是透過將研究著作公開供使用者自由取閱，以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力，NTU Scholars即為本校的開放取用典藏（OA Archive）平台。（點選深入了解OA）

  • 請確認所上傳的全文是原創的內容，若該文件包含部分內容的版權非匯入者所有，或由第三方贊助與合作完成，請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔，可使用Open policy finder網站查詢，以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science